Anixa Biosciences (ANIX) Institutional Ownership → Trump’s arrest is phase one (From Porter & Company) (Ad) Free ANIX Stock Alerts $2.43 -0.11 (-4.33%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Anixa Biosciences (NASDAQ:ANIX)CurrentInstitutional OwnershipPercentage29.13%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$2.03MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$97.58K Get ANIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Anixa Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANIX Institutional Buying and Selling by Quarter Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. Anixa Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC16,156$50K0.0%+47.2%0.051% 5/6/2024 Staley Capital Advisers Inc.10,000$31K0.0%N/A0.031% 4/24/2024 Simplicity Wealth LLC13,969$44K0.0%N/A0.044% 1/24/2024 International Assets Investment Management LLC54,320$2.11M0.0%+274.6%0.171% 11/9/2023 UBS Group AG604,439$1.98M0.0%-4.7%1.945% 10/24/2023 Dakota Wealth Management15,000$49K0.0%N/A0.048% Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/24/2023 Mission Wealth Management LP501,168$1.64M0.1%N/A1.613% 7/25/2023 Concorde Asset Management LLC15,481$50K0.0%N/A0.050% 7/14/2023 Westside Investment Management Inc.13,800$44K0.0%N/A0.045% 5/1/2023 Virtu Financial LLC18,409$79K0.0%N/A0.060% 4/27/2023Simplicity Solutions LLC15,481$67K0.0%N/A0.050% 4/19/2023 International Assets Investment Management LLC14,500$62K0.0%+31.8%0.047% 2/8/2023 Cambridge Investment Research Advisors Inc.40,100$170K0.0%+167.3%0.130% 2/7/2023 Nations Financial Group Inc. IA ADV13,000$55K0.0%N/A0.042% 1/30/2023 International Assets Investment Management LLC11,000$47K0.0%N/A0.036% 11/10/2022 UBS Group AG621,691$3.06M0.0%+2.7%2.028% 10/25/2022 Raymond James & Associates60,846$299K0.0%-7.1%0.198% 10/17/2022 Cambridge Investment Research Advisors Inc.15,000$74K0.0%N/A0.049% 7/22/2022 Gemmer Asset Management LLC35,000$107K0.0%N/A0.115% 4/28/2022 Keybank National Association OH15,510$42K0.0%N/A0.051% 2/22/2022 Tyler Stone Wealth Management21,008$62K0.0%N/A0.070% 2/14/2022 Long Focus Capital Management LLC21,297$63K0.0%N/A0.071% 2/10/2022B. Riley Wealth Management Inc.17,000$50K0.0%+41.7%0.056% 2/8/2022 Raymond James & Associates56,902$169K0.0%+10.4%0.189% 11/16/2021 Adirondack Trust Co.7,000$33K0.0%N/A0.023% 11/15/2021 Marshall Wace LLP41,973$200K0.0%N/A0.140% 11/12/2021 Renaissance Technologies LLC212,200$1.01M0.0%+70.4%0.709% 11/12/2021 Geode Capital Management LLC263,951$1.26M0.0%+23.5%0.881% 11/9/2021 BlackRock Inc.110,292$525K0.0%-6.6%0.368% 11/2/2021 Raymond James & Associates51,550$246K0.0%-4.6%0.172% 11/1/2021 Cedar Brook Financial Partners LLC10,000$48K0.0%N/A0.033% 10/22/2021 Spire Wealth Management14,500$69K0.0%-17.1%0.048% 10/8/2021 Wealth Alliance Advisory Group LLC16,413$78K0.0%N/A0.055% 8/16/2021 State Street Corp23,287$90K0.0%N/A0.078% 8/13/2021 Renaissance Technologies LLC124,499$483K0.0%N/A0.416% 8/13/2021 Northern Trust Corp61,282$238K0.0%+24.8%0.205% 8/13/2021 Geode Capital Management LLC213,804$829K0.0%+26.5%0.714% 8/13/2021 Vanguard Group Inc.1,302,231$5.05M0.0%+1.7%4.348% 8/11/2021 Bank of New York Mellon Corp43,302$168K0.0%-15.0%0.145% 5/21/2021 Citadel Advisors LLC19,682$92K0.0%+35.8%0.063% Trump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.5/18/2021 Citadel Advisors LLC19,682$92K0.0%+35.8%0.063% 5/18/2021 Jane Street Group LLC26,093$122K0.0%N/A0.083% 5/14/2021 First Manhattan Co.6,500$30K0.0%N/A0.021% 5/14/2021 Stifel Financial Corp20,000$94K0.0%N/A0.064% 5/13/2021 Barclays PLC9,998$47K0.0%N/A0.032% 5/12/2021 Geode Capital Management LLC168,958$790K0.0%+51.1%0.538% 5/12/2021 UBS Group AG587,481$2.75M0.0%-5.0%1.869% 5/7/2021 BlackRock Inc.102,220$478K0.0%+8.8%0.325% 4/28/2021 Wealth Alliance Advisory Group LLC20,100$94K0.0%N/A0.064% 4/27/2021 Dorsey Wright & Associates8,093$38K0.4%N/A0.026% 4/27/2021 Concorde Asset Management LLC13,000$61K0.0%N/A0.041% 2/11/2021B. Riley Wealth Management Inc.12,000$37K0.0%N/A0.046% 2/11/2021 Northern Trust Corp49,291$151K0.0%-5.2%0.189% 2/9/2021 Bank of New York Mellon Corp51,969$160K0.0%+32.0%0.199% 2/5/2021 BlackRock Inc.93,942$289K0.0%+8.0%0.360% 11/17/2020 Jane Street Group LLC18,495$45K0.0%N/A0.078% 11/13/2020 Morgan Stanley14,484$35K0.0%-43.1%0.061% (Data available from 1/1/2016 forward) ANIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANIX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Anixa Biosciences. The most heavily invested institutionals were International Assets Investment Management LLC ($2.11M), UBS Group AG ($1.98M), Mission Wealth Management LP ($1.64M), Raymond James & Associates ($299K), Cambridge Investment Research Advisors Inc. ($170K), Gemmer Asset Management LLC ($107K), and Simplicity Solutions LLC ($67K).Learn more on ANIX's institutional investors. What percentage of Anixa Biosciences stock is owned by institutional investors? 29.13% of Anixa Biosciences stock is owned by institutional investors. Learn more on ANIX's institutional investor holdings. Which institutional investors have been buying Anixa Biosciences stock? Of the 13 institutional investors that purchased Anixa Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Mission Wealth Management LP ($501.17K), International Assets Investment Management LLC ($54.32K), Cambridge Investment Research Advisors Inc. ($40.10K), Gemmer Asset Management LLC ($35K), Virtu Financial LLC ($23.59K), UBS Group AG ($16.29K), and Concorde Asset Management LLC ($15.48K). How much institutional buying is happening at Anixa Biosciences? Institutional investors have bought a total of 767,196 shares in the last 24 months. This purchase volume represents approximately $2.66M in transactions. Which Anixa Biosciences major shareholders have been selling company stock? The following institutional investors have sold Anixa Biosciences stock in the last 24 months: UBS Group AG ($29.84K), and Raymond James & Associates ($4.67K). How much institutional selling is happening at Anixa Biosciences? Institutional investors have sold a total of 34,512 shares in the last 24 months. This volume of shares sold represents approximately $120.56K in transactions. Related Companies: Enzo Biochem Major Shareholders Psychemedics Major Shareholders Atea Pharmaceuticals Major Shareholders Q32 Bio Major Shareholders Kamada Major Shareholders XOMA Major Shareholders ESSA Pharma Major Shareholders Emergent BioSolutions Major Shareholders Inozyme Pharma Major Shareholders Vanda Pharmaceuticals Major Shareholders This page (NASDAQ:ANIX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.